Medical Foods For Inborn Errors of Metabolism Market 2027 By Product, Age group, Disease, Forms, Packaging, Distribution Channel, Region and Geography | The Insight Partners

Medical Foods for Inborn Errors of Metabolism Market Forecast to 2027 - COVID-19 Impact and Global Analysis by Product (Amino Acid, Glytactin with GMP, Amino Acid-Modified Infant Formula with Iron, Low-Calcium/Vitamin D-Free Infant Formula with Iron, Low Protein Food, and Others); Age group (Infants, Weaning, Adolescent, and Adults); Disease (Phenylketonuria (PKU), Maple Syrup Urine Disease (MSUD), Homocystinuria, Urea Cycle Disorders, Methylmalonic Acidemia, Organic Acidurias, Propionic Acidemia, Isovaleric Acidemia, Disorders of Leucine Metabolism, Glutaric Acidemia Type I, Renal Disease, Tyrosinemia Types I and II, and Others); Forms (Powder, Liquids, Gels, and Others); Packaging (Can, Jar, Packets, Bottle, and Others); Distribution Channel (Retail Pharmacies, Hospital Pharmacies, Online Pharmacies, Drug Stores, and Others); and Geography

Publication Month: Jun 2020 | Report Code: TIPRE00011389 | No. of Pages: 243 | Category: Pharmaceuticals | Status: Published
Covid

The medical foods for inborn errors of metabolism market are anticipated to reach US$ 5,768.79 million by 2027 from US$ 2,507.80 million in 2019. The market is projected to grow with a CAGR of 11.2% from 2020 to 2027.

 

Medical food is the specialized food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however, they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable for their particular condition that must be followed for the lifetime.

 

Lucrative Regions for Medical Foods for Inborn Errors of Metabolism Market

Lucrative Regions for Medical Foods for Inborn Errors of Metabolism Market

Get more information on this report :


 


Market Insights

Increasing Incidences of Inborn Errors of Metabolism

Inborn errors of metabolism refer to inherited disorders due to mutation in genes coding for proteins functioning in metabolism. The inborn errors of metabolism are a heterogeneous group of disorders and are likely to be inherited through spontaneous mutation. The diseases usually involve failure of metabolic pathways that are either involved in breakdown or storage of biomolecules, such as carbohydrates, proteins, and fatty acids. According to the survey report published by St. Luke's University Health Network in May 2020, inborn errors occur in one among 2,500 births making them significantly common.

A few commonly occurring inborn errors of metabolism include phenylketonuria (PKU), maple syrup urine disease, galactosemia, and fructose intolerance. According to the National Organization for Rare Diseases (NORD), PKU is an inborn error of metabolism that is detectable during the first days of life through newborn screening. The reported incidence of PKU from various newborn-screening programs ranges from one in 13,000 to 19,000 births in the US. The disease is known to affect people majorly from the ethnic backgrounds. Furthermore, according to the US National Library of Medicine (NLM), maple syrup urine disease affects ~1 in 185,000 infants across the world. The NLM also states that the disorder occurs frequently among the old order mennonite population, with an approximate incidence of about one in 380 newborns, which is significantly high.

A few commonly occurring inborn errors of metabolism include homocystinurea, which is an inherited disease that makes the body unable to process certain amino acids properly. According to the NORD, the frequency of homocystinurea in general population is one in 344,000. The prevalence of the disease in Ireland was estimated to be one in 65,000, and in Germany it was estimated to be one in 17,500. Medical foods for inborn errors of metabolism act as nutritional treatment for patients with limited or compromised capacity to ingest, digest, absorb, or metabolize ordinary foods or nutrients. Thus, the increasing incidence of these diseases worldwide is expected to augment the demand for medical foods for inborn errors of metabolism, thereby supporting the market growth.

 

Product-Based Market Insights

Based on product, the medical foods for inborn errors of metabolism market is segmented into amino acid, glytactin with GMP, amino acid-modified infant formula with iron, low-calcium/vitamin D-free infant formula with iron, low protein food, and others. In 2019, the amino acid segment accounted for the largest share of the global medical foods for inborn errors of metabolism market. The growth of the segment attributes to large number of amino acid based product availability in the market. Furthermore, the number of patients suffering from amino acid disorders is also significantly higher leading to rising demand for these products during the forecast period.

 

Global Medical Foods for Inborn Errors of Metabolism Market, by Product – 2019 and 2027

Global Medical Foods for Inborn Errors of Metabolism Market, by Product – 2019 and 2027

Get more information on this report :



Age Group-Based Market Insights

Based on age group, the global medical foods for inborn errors of metabolism market is segmented into infants, weaning, adolescents, and adults. In 2019, the infants segment held the largest share of the market and is expected to witness growth at a significant rate during the forecast period from 2019 to 2027.

 

Disease-Based Market Insights

Based on disease, the global medical foods for inborn errors of metabolism market is segmented into phenylketonuria (PKU), maple syrup urine disease (MSUD), homocystonuria, urea cycle disorders, methylmelonic academia, organic acidureas, propionic academia, isovaleric academia, disorders of leucine metabolism, glutaric academia type-1, renal disease, tyrosinemia types I and II, and others. In 2019, the phenylketonuria segment held the largest share of the market; however, the glutaric academia type-1 segment is expected to grow at a fastest rate during the forecast period.

 

Form-Based Market Insights

Based on form, the global medical foods for inborn errors of metabolism market is segmented into powder, liquids, gels, and others. In 2019, the powder segment held the largest share of the market and the same segment is also expected to grow at the fastest rate during the forecast period.

Packaging-Based Market Insights

Based on packaging, the global medical foods for inborn errors of metabolism market is segmented into can, jar, packet, bottle, and others. In 2019, the can segment held the largest share of the market; however, the packets segment is expected to grow at the fastest rate during the forecast period.

 

Distribution Channel-Based Market Insights

Based on distribution channel, the global medical food for inborn errors of metabolism market is segmented into retail pharmacies, hospital pharmacies, online pharmacies, drug stores and others. In 2019, the retail pharmacies segment held the largest share of the market and the same segment is expected to grow at the fastest rate during the forecast period.

 

Strategic Insights

Product approvals, product launches, expansions, and acquisitions are the most commonly adopted strategies by companies to expand their footprints worldwide and meet the growing demand by broadening their product portfolios. For instance, in February 2020, Galen Limited introduced the PKU EASY Microtabs, an innovative medical food product for people with the rare inherited/inborn metabolic disorder phenylketonuria (PKU) in the UK market. The product provides a palatable alternative to other protein substitutes available in the market. The product is beneficial to the patients aged eight and above to manage their incurable condition and consume the daily protein needs.

 

Global Medical Foods for Inborn Errors of Metabolism Market – By Product

  • Amino Acid
  • Glytactin with GMP
  • Amino Acid-Modified Infant Formula With Iron
  • Low-Calcium/Vitamin D-free Infant Formula With Iron
  • Low Protein Food
  • Others

Global Medical Foods for Inborn Errors of Metabolism Market – By Age Group

  • Infants
  • Weaning
  • Adolescents
  • Adults

Global Medical Foods for Inborn Errors of Metabolism Market – By Disease

  • Phenylketonuria (PKU)
  • Maple Syrup Urine Disease (MSUD)
  • Homocystinuria
  • Urea Cycle Disorders
  • Methylmalonic Acidemia
  • Organic Acidurias
  • Propionic Acidemia
  • Isovaleric aciDemia
  • Disorders of Leucine Metabolism
  • Glutaric Acidemia Type I
  • Renal Disease
  • Tyrosinemia Types I and II
  • Others

Global Medical Foods for Inborn Errors of Metabolism Market – By Form

  • Powder
  • Liquid
  • Gels
  • Others

Global Medical Foods for Inborn Errors of Metabolism Market – By Packaging

  • Can
  • Jar
  • Packets
  • Bottle
  • Others

Global Medical Foods for Inborn Errors of Metabolism Market – By Distribution Channel

  • Retail Pharmacies
  • Hospital Pharmacies
  • Online Pharmacies
  • Drugstores
  • Others

Medical Foods for Inborn Errors of Metabolism Market – By Geography

  • North America
    • US
    • Canada
    • Mexico
  • Europe
    • France
    • Germany
    • Italy
    • UK
    • Spain
  • Asia Pacific
    • China
    • India
    • South Korea
    • Japan
    • Australia
  • Middle East and Africa
    • South Africa
    • Saudi Arabia
    • UAE
  • South and Central America
    • Brazil
    • Argentina

 

Company Profiles

  • Nestlé
  • Abbott
  • Reckitt Benckiser Group Plc
  • Ajinomoto Co. Inc.
  • Solace Nutrition
  • Primus Pharmaceuticals, Inc.
  • BioMarin Pharmaceutical Inc.
  • Danone SA
  • Galen Limited
  • PKU-MDMIL

 

1.             Introduction

1.1       Scope of the Study

1.2       The Insight Partners Research Report Guidance

1.3       Market Segmentation

1.3.1        Medical Foods for Inborn Errors of Metabolism Market – By Product

1.3.2        Medical Foods for Inborn Errors of Metabolism Market – By Age Group

1.3.3        Medical Foods for Inborn Errors of Metabolism Market – By Disease

1.3.4        Medical Foods for Inborn Errors of Metabolism Market – By Form

1.3.5        Medical Foods for Inborn Errors of Metabolism Market – By Packaging

1.3.6        Medical Foods for Inborn Errors of Metabolism Market – By Distribution Channel

1.3.7        Medical Foods for Inborn Errors of Metabolism Market – By Geography

2.             Medical Foods for Inborn Errors of Metabolism Market – Key Takeaways

3.             Research Methodology

3.1       Coverage

3.2       Secondary Research

3.3       Primary Research

4.             Medical Foods for Inborn Errors of Metabolism Market Landscape

4.1       Overview

4.2       PEST Analysis

4.2.1        North America – PEST Analysis

4.2.2        Europe – PEST Analysis

4.2.3        Asia-Pacific – PEST Analysis

4.2.4        Middle East and Africa – PEST Analysis

4.2.5        South and Central America – PEST Analysis

4.3       Expert Opinions

5.             Global Medical Foods for Inborn Errors of Metabolism Market – Industry Dynamics

5.1       Market Drivers

5.1.1        Increasing Incidences of Inborn Errors of Metabolism

5.1.2        Growing Preference Toward Dietary Supplements

5.2       Market Restraints

5.2.1        Issues with Medical Foods for Inborn Errors of Metabolism

5.3       Market Opportunities

5.3.1        Developing Healthcare Industry Worldwide

5.4       Future Trends

5.4.1        Growing Online Distribution Platforms

5.5       Impact Analysis of Drivers and Restraints

6.             Medical Foods for Inborn Errors of Metabolism Market – Global Analysis

6.1       Global Medical Foods for Inborn Errors of Metabolism Market - Overview

6.2       Global Medical Foods for Inborn Errors of Metabolism Market – Revenue Forecasts and Analysis

6.3       Global Medical Foods for Inborn Errors of Metabolism Market, By Geography - Forecast And Analysis

6.4       Market Positioning of Key Players

7.             Medical Foods for Inborn Errors of Metabolism Market Analysis– by Product

7.1       Overview

7.2       Medical Foods for Inborn Errors of Metabolism Market, By Product, 2019 & 2027 (%)

7.2.1        Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Product  (US$ Million)

7.3       Amino Acid

7.3.1        Overview

7.3.2        Amino Acid Market Revenue and Forecasts to 2027 (US$ Million)

7.4       Glytactin with GMP

7.4.1        Overview

7.4.2        Glytactin with GMP Market Revenue and Forecasts to 2027 (US$ Million)

7.5       Amino Acid-Modified Infant Formula With Iron

7.5.1        Overview

7.5.2        Amino Acid-Modified Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

7.6       Low-Calcium/Vitamin D-Free Infant Formula With Iron

7.6.1        Overview

7.6.2        Low-Calcium/Vitamin D-Free Infant Formula With Iron Market Revenue and Forecasts to 2027  (US$ Million)

7.7       Low Protein Food

7.7.1        Overview

7.7.2        Low Protein Food Market Revenue and Forecasts to 2027 (US$ Million)

7.8       Others

7.8.1        Overview

7.8.2        Others Market Revenue and Forecasts to 2027 (US$ Million)

8.             Medical Foods for Inborn Errors of Metabolism Market Analysis– by Age Group

8.1       Overview

8.2       Medical Foods for Inborn Errors of Metabolism Market, By Age Group, 2019 & 2027 (%)

8.2.1        Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Age Group (US$ Million)

8.3       Infants

8.3.1        Overview

8.3.2        Infants Market Revenue and Forecasts to 2027 (US$ Million)

8.4       Weaning

8.4.1        Overview

8.4.2        Weaning Market Revenue and Forecasts to 2027 (US$ Million)

8.5       Adolescent

8.5.1        Overview

8.5.2        Adolescent Market Revenue and Forecasts to 2027 (US$ Million)

8.6       Adults

8.6.1        Overview

8.6.2        Adults Market Revenue and Forecasts to 2027 (US$ Million)

9.             Medical Foods for Inborn Errors of Metabolism Market Analysis– by Disease

9.1       Overview

9.2       Medical Foods for Inborn Errors of Metabolism Market, By Disease, 2019 & 2027 (% Share)

9.2.1        Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Disease  (US$ Million)

9.3       Phenylketonuria (PKU)

9.3.1        Overview

9.3.2        Phenylketonuria (PKU) Market Revenue and Forecasts to 2027 (US$ Million)

9.4       Maple Syrup Urine Disease (MSUD)

9.4.1        Overview

9.4.2        Maple Syrup Urine Disease (MSUD)Market Revenue and Forecasts to 2027 (US$ Million)

9.5       Homocystinuria

9.5.1        Overview

9.5.2        Homocystinuria Market Revenue and Forecasts to 2027 (US$ Million)

9.6       Urea Cycle Disorders

9.6.1        Overview

9.6.2        Urea Cycle Disorders Market Revenue and Forecasts to 2027 (US$ Million)

9.7       Methylmalonic Acidemia

9.7.1        Overview

9.7.2        Methylmalonic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

9.8       Organic Acidurias

9.8.1        Overview

9.8.2        Organic Acidurias Market Revenue and Forecasts to 2027 (US$ Million)

9.9       Propionic Acidemia

9.9.1        Overview

9.9.2        Propionic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

9.10    Isovaleric Acidemia

9.10.1     Overview

9.10.2     Isovaleric Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

9.11    Disorders of Leucine Metabolism

9.11.1     Overview

9.11.2     Disorders of Leucine Metabolism Market Revenue and Forecasts to 2027 (US$ Million)

9.12    Glutaric Acidemia Type-I

9.12.1     Overview

9.12.2     Glutaric Acidemia Type-I Market Revenue and Forecasts to 2027 (US$ Million)

9.13    Renal Disease

9.13.1     Overview

9.13.2     Renal Disease Market Revenue and Forecasts to 2027 (US$ Million)

9.14    Tyrosinemia Type I and II

9.14.1     Overview

9.14.2     Tyrosinemia Type I and II Market Revenue and Forecasts to 2027 (US$ Million)

9.15    Others

9.15.1     Overview

9.15.2     Others Market Revenue and Forecasts to 2027 (US$ Million)

10.          Medical Foods for Inborn Errors of Metabolism Market Analysis– by Form

10.1    Overview

10.2    Medical Foods for Inborn Errors of Metabolism Market, By Form, 2019 & 2027 (% Share)

10.2.1     Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Form  (US$ Million)

10.3    Powder

10.3.1     Overview

10.3.2     Powder Market Revenue and Forecasts to 2027 (US$ Million)

10.4    Liquids

10.4.1     Overview

10.4.2     Liquids Market Revenue and Forecasts to 2027 (US$ Million)

10.5    Gels

10.5.1     Overview

10.5.2     Gels Market Revenue and Forecasts to 2027 (US$ Million)

10.6    Others

10.6.1     Overview

10.6.2     Others Market Revenue and Forecasts to 2027 (US$ Million)

11.          Medical Foods for Inborn Errors of Metabolism Market Analysis– by Packaging

11.1    Overview

11.2    Medical Foods for Inborn Errors of Metabolism Market, By Packaging, 2019 & 2027 (% Share)

11.2.1     Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Packaging (US$ Million)

11.3    Can

11.3.1     Overview

11.3.2     Can Market Revenue and Forecasts to 2027 (US$ Million)

11.4    Jar

11.4.1     Overview

11.4.2     Jar Market Revenue and Forecasts to 2027 (US$ Million)

11.5    Packet

11.5.1     Overview

11.5.2     Packet Market Revenue and Forecasts to 2027 (US$ Million)

11.6    Bottle

11.6.1     Overview

11.6.2     Bottle Market Revenue and Forecasts to 2027 (US$ Million)

11.7    Others

11.7.1     Overview

11.7.2     Others Market Revenue and Forecasts to 2027 (US$ Million)

12.          Medical Foods for Inborn Errors of Metabolism Market Analysis– by Distribution Channel

12.1    Overview

12.2    Medical Foods for Inborn Errors of Metabolism Market, By Distribution Channel, 2019 & 2027 (% Share)

12.2.1     Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Distribution Channel (US$ Million)

12.3    Retail Pharmacies

12.3.1     Overview

12.3.2     Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

12.4    Hospital Pharmacies

12.4.1     Overview

12.4.2     Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

12.5    Online Pharmacies

12.5.1     Overview

12.5.2     Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

12.6    Drugstores

12.6.1     Overview

12.6.2     Drugstores Market Revenue and Forecasts to 2027 (US$ Million)

12.7    Others

12.7.1     Overview

12.7.2     Others Market Revenue and Forecasts to 2027 (US$ Million)

13.          Medical Foods for Inborn Errors of Metabolism Market – Geographic Analysis

13.1    North America: Medical Foods for Inborn Errors of Metabolism Market

13.1.1     Overview

13.1.2     North America: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.3     North America: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.1.4     North America: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.1.5     North America: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.1.6     North America: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.1.7     North America: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.1.8     North America: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.1.9     North America: Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

13.1.10   US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.10.1 US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.10.1.1 US: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027  (USD Million)

13.1.10.1.2 US: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027  (USD Million)

13.1.10.1.3 US: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

13.1.10.1.4 US: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

13.1.10.1.5 US: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027  (USD Million)

13.1.10.1.6 US: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.1.11   Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.1.11.1 Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.1 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.2 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.3 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.4 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.1.11.1.5 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.1.11.1.6 Canada: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.1.12   Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.12.1 Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.1.12.1.1 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.1.12.1.2 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.1.12.1.3 Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.1.12.1.4 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

13.1.12.1.5 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.1.12.1.6 Mexico:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.2    Europe: Medical Foods For Inborn Errors Of Metabolism Market

13.2.1     Overview

13.2.2     Europe: Medical Foods For Inborn Errors Of Metabolism Market - Revenue and Forecast to 2027  (USD Million)

13.2.3     Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.4     Europe: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027  (USD Million)

13.2.5     Europe: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.6     Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.7     Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.8     Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.2.9     Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

13.2.10   Germany: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.10.1 Germany: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.10.1.1 Germany: Medical Foods for Inborn Errors of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.10.1.2 Germany: Medical Foods for Inborn Errors of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.2.10.1.3 Germany: Medical Foods for Inborn Errors of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.10.1.4 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.10.1.5 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.10.1.6 Germany: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.2.11   UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.2.11.1 UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.11.1.1 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.11.1.2 UK: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.2.11.1.3 UK: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.11.1.4 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.11.1.5 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.11.1.6 UK: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.2.12   France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.2.12.1 France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.12.1.1 France: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.12.1.2 France: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.2.12.1.3 France: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.12.1.4 France: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.12.1.5 France: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.12.1.6 France: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.2.13   Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.2.13.1 Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.13.1.1 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.13.1.2 Spain: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027  (USD Million)

13.2.13.1.3 Spain: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.13.1.4 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.13.1.5 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.13.1.6 Spain: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.2.14   Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.2.14.1 Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.2.14.1.1 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.2.14.1.2 Italy: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.2.14.1.3 Italy: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.2.14.1.4 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.2.14.1.5 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.2.14.1.6 Italy: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.3    Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market

13.3.1     Overview

13.3.2     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market- Revenue and Forecast to 2027 (USD Million)

13.3.3     Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.3.4     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.3.5     Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.3.6     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.3.7     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.8     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.3.9     Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

13.3.10   China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.10.1 China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.10.1.1 China:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027  (USD Million)

13.3.10.1.2 China:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.3.10.1.3 China: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

13.3.10.1.4 China:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

13.3.10.1.5 China:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.10.1.6 China:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.3.11   Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.3.11.1 Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.11.1.1 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.3.11.1.2 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027  (USD Million)

13.3.11.1.3 Japan: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.3.11.1.4 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.3.11.1.5 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.11.1.6 Japan:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.3.12   India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.3.12.1 India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.1 India:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.2 India:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027  (USD Million)

13.3.12.1.3 India: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.4 India:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.3.12.1.5 India:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.12.1.6 India:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.3.13   South Korea:Medical Foods for Inborn Errors of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

13.3.13.1 South Korea:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.13.1.1 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.3.13.1.2 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.3.13.1.3 South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.3.13.1.4 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.3.13.1.5 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.13.1.6 South Korea:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.3.14   Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.3.14.1 Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.3.14.1.1 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Product – Revenue and Forecast to 2027 (USD Million)

13.3.14.1.2 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

13.3.14.1.3 Australia: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

13.3.14.1.4 Australia: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

13.3.14.1.5 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

13.3.14.1.6 Australia:Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

13.4    Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market

13.4.1     Overview

13.4.2     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market- Revenue and Forecast to 2027 (USD Million)

13.4.3     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.4.4     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group,  2018–2027 (USD Million)

13.4.5     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.4.6     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.4.7     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.4.8     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.4.9     Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Country,  2019 & 2027 (%)

13.4.10   Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

13.4.10.1 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

13.4.10.1.1 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.4.10.1.2 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.4.10.1.3 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.4.10.1.4 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.4.10.1.5 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.4.10.1.6 Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.4.11   UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

13.4.11.1 UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

13.4.11.1.1 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.4.11.1.2 UAE: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.4.11.1.3 UAE: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.4.11.1.4 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.4.11.1.5 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.4.11.1.6 UAE: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.4.12   South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

13.4.12.1 South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

13.4.12.1.1 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.4.12.1.2 South Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027  (USD Million)

13.4.12.1.3 South Africa: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027  (USD Million)

13.4.12.1.4 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.4.12.1.5 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.4.12.1.6 South Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.5    South and Central America: Medical Foods For Inborn Errors Of Metabolism Market

13.5.1     Overview

13.5.2     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market - Revenue and Forecast to 2027 (US$ Million)

13.5.3     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Product,  2018–2027 (USD Million)

13.5.4     South and Central America: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.5.5     South and Central America: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease,  2018–2027 (USD Million)

13.5.6     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.5.7     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.5.8     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027 (USD Million)

13.5.9     South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Country,  2019 & 2027 (%)

13.5.10   Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.5.10.1 Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.5.10.1.1 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.5.10.1.2 Brazil: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.5.10.1.3 Brazil: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.5.10.1.4 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.5.10.1.5 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.5.10.1.6 Brazil: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

13.5.11   Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

13.5.11.1 Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

13.5.11.1.1 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Product, 2018–2027 (USD Million)

13.5.11.1.2 Argentina: Medical Foods For Inborn Errors Of Metabolism, Market, by Age Group, 2018–2027 (USD Million)

13.5.11.1.3 Argentina: Medical Foods For Inborn Errors Of Metabolism, Market, by Disease, 2018–2027 (USD Million)

13.5.11.1.4 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Forms, 2018–2027 (USD Million)

13.5.11.1.5 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Packing, 2018–2027 (USD Million)

13.5.11.1.6 Argentina: Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel, 2018–2027  (USD Million)

14.          Impact of COVID-19 Pandemic on Global Medical Foods for Inborn Errors of Metabolism Market

14.1    North America: Impact Assessment of COVID-19 Pandemic

14.2    Europe: Impact Assessment Of COVID-19 Pandemic

14.3    Asia-Pacific: Impact Assessment of COVID-19 Pandemic

14.4    Rest of the World: Impact Assessment of COVID-19 Pandemic

15.          Medical Foods For Inborn Errors Of Metabolism Market – Industry Landscape

15.1    Overview

15.2    Growth Strategies Done by the Companies in the Market, (%)

15.3    Organic Developments

15.3.1     Overview

15.4    Inorganic Developments

15.4.1     Overview

16.          Company Profiles

16.1    Nestlé

16.1.1     Key Facts

16.1.2     Business Description

16.1.3     Products and Services

16.1.4     Financial Overview

16.1.5     SWOT Analysis

16.1.6     Key Developments

16.2    Abbott

16.2.1     Key Facts

16.2.2     Business Description

16.2.3     Products and Services

16.2.4     Financial Overview

16.2.5     SWOT Analysis

16.2.6     Key Developments

16.3    Reckitt Benckiser Group Plc

16.3.1     Key Facts

16.3.2     Business Description

16.3.3     Products and Services

16.3.4     Financial Overview

16.3.5     SWOT Analysis

16.3.6     Key Developments

16.4    Ajinomoto Co. Inc.

16.4.1     Key Facts

16.4.2     Business Description

16.4.3     Products and Services

16.4.4     Financial Overview

16.4.5     SWOT Analysis

16.4.6     Key Developments

16.5    Solace Nutrition

16.5.1     Key Facts

16.5.2     Business Description

16.5.3     Products and Services

16.5.4     Financial Overview

16.5.5     SWOT Analysis

16.5.6     Key Developments

16.6    Primus Pharmaceuticals, Inc.

16.6.1     Key Facts

16.6.2     Business Description

16.6.3     Products and Services

16.6.4     Financial Overview

16.6.5     SWOT Analysis

16.6.6     Key Developments

16.7    BioMarin Pharmaceutical Inc.

16.7.1     Key Facts

16.7.2     Business Description

16.7.3     Products and Services

16.7.4     Financial Overview

16.7.5     SWOT Analysis

16.7.6     Key Developments

16.8    Danone SA

16.8.1     Key Facts

16.8.2     Business Description

16.8.3     Products and Services

16.8.4     Financial Overview

16.8.5     SWOT Analysis

16.8.6     Key Developments

16.9    Galen Limited

16.9.1     Key Facts

16.9.2     Business Description

16.9.3     Products and Services

16.9.4     Financial Overview

16.9.5     SWOT Analysis

16.9.6     Key Developments

16.10 PKU-MDMIL

16.10.1   Key Facts

16.10.2   Business Description

16.10.3   Products and Services

16.10.4   Financial Overview

16.10.5   SWOT Analysis

16.10.6   Key Developments

17.          Appendix

17.1    About The Insight Partners

17.2    Glossary of Terms

 

LIST OF TABLES

Table 1.             Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Product  (US$ Million)

Table 2.             Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecasts to 2027, By Age Group (US$ Million)

Table 3.             Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Disease  (US$ Million)

Table 4.             Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Form(US$ Million)

Table 5.             Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Packaging  (US$ Million)

Table 6.             Medical Foods for Inborn Errors of Metabolism Market Revenue And Forecasts to 2027, By Distribution Channel (US$ Million)

Table 7.             North America: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 8.             North America: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 9.             North America: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 10.          North America: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 11.          North America: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 12.          North America: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 13.          US: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 14.          US: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027  (USD Million)

Table 15.          US: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

Table 16.          US: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 17.          US: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027  (USD Million)

Table 18.          US: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 19.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 20.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 21.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 22.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 23.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 24.          Canada: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 25.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 26.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 27.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 28.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 29.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 30.          Mexico: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 31.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 32.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 33.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 34.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 35.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 36.          Europe Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 37.          Germany Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 38.          Germany Medical Foods for Inborn Errors of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 39.          Germany Medical Foods for Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 40.          Germany Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 41.          Germany Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 42.          Germany Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 43.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 44.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 45.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

Table 46.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 47.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027  (USD Million)

Table 48.          UK Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 49.          France Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 50.          France Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 51.          France Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 52.          France Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 53.          France Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 54.          France Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 55.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 56.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 57.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 58.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 59.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 60.          Spain Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 61.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 62.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 63.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

Table 64.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 65.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027  (USD Million)

Table 66.          Italy Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 67.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 68.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 69.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 70.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 71.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 72.          Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 73.          China: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 74.          China: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 75.          China: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 76.          China: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 77.          China: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 78.          China: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 79.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 80.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 81.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 82.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 83.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 84.          Japan: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 85.          India: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 86.          India: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 87.          India: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

Table 88.          India: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027  (USD Million)

Table 89.          India: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 90.          India: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 91.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 92.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 93.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 94.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 95.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 96.          South Korea: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 97.          Australia: Medical Foods for Inborn Errors of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 98.          Australia: Medical Foods for Inborn Errors of Metabolism Market, by Age group – Revenue and Forecast to 2027 (USD Million)

Table 99.          Australia: Medical Foods for Inborn Errors of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 100.       Australia: Medical Foods for Inborn Errors of Metabolism Market, by Form – Revenue and Forecast to 2027 (USD Million)

Table 101.       Australia: Medical Foods for Inborn Errors of Metabolism Market, by Packaging– Revenue and Forecast to 2027 (USD Million)

Table 102.       Australia: Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel– Revenue and Forecast to 2027 (USD Million)

Table 103.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 104.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 105.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 106.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 107.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 108.       Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 109.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 110.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 111.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 112.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 113.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 114.       Saudi Arabia Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 115.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 116.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 117.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027  (USD Million)

Table 118.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 119.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027  (USD Million)

Table 120.       UAE Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 121.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 122.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 123.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 124.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 125.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 126.       South Africa Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 127.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 128.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 129.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 130.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 131.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 132.       South and Central America Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 133.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027  (USD Million)

Table 134.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 135.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 136.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027  (USD Million)

Table 137.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 138.       Brazil Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 139.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Product– Revenue and Forecast to 2027 (USD Million)

Table 140.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Age Group – Revenue and Forecast to 2027 (USD Million)

Table 141.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Disease – Revenue and Forecast to 2027 (USD Million)

Table 142.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Forms – Revenue and Forecast to 2027 (USD Million)

Table 143.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Packing – Revenue and Forecast to 2027 (USD Million)

Table 144.       Argentina Medical Foods For Inborn Errors Of Metabolism Market, by Distribution Channel – Revenue and Forecast to 2027 (USD Million)

Table 145.       Organic Developments Done By Companies

Table 146.       Inorganic Developments Done By Companies

Table 147.       Glossary of Terms, Medical Foods for Inborn Errors of Metabolism Market

 

 

LIST OF FIGURES

Figure 1.           Medical Foods for Inborn Errors of Metabolism Market Segmentation

Figure 2.           Medical Foods for Inborn Errors of Metabolism Market – By Geography

Figure 3.           Global Medical Foods for Inborn Errors of Metabolism Market Overview

Figure 4.           Amino Acid Segment Held Largest Share of Product Segment In Medical Foods for Inborn Errors of Metabolism Market

Figure 5.           Asia-Pacific Region Is Expected to Show Remarkable Growth During the Forecast Period

Figure 6.           Global Medical Foods for Inborn Errors of Metabolism Market, By Geography (US$ Million)

Figure 7.           Global Medical Foods for Inborn Errors of Metabolism Market- Leading Country Markets (US$ Million)

Figure 8.           Global Medical Foods for Inborn Errors of Metabolism Market, Industry Landscape

Figure 9.           North America PEST Analysis

Figure 10.        Europe PEST Analysis

Figure 11.        Asia-Pacific PEST Analysis

Figure 12.        Middle East and Africa PEST Analysis

Figure 13.        South and Central America PEST Analysis

Figure 14.        Medical Foods for Inborn Errors of Metabolism Market Impact Analysis of Drivers and Restraints

Figure 15.        Global Medical Foods for Inborn Errors of Metabolism Market – Revenue Forecasts and Analysis – 2018- 2027

Figure 16.        Global Medical Foods for Inborn Errors of Metabolism Market– By Geography Forecast and Analysis –  2019- 2027

Figure 17.        Market Positioning Of Key Players In Global Medical Foods for Inborn Errors of Metabolism Market

Figure 18.        Medical Foods for Inborn Errors of Metabolism Market, by Product, 2019 & 2027 (%)

Figure 19.        Amino Acid Market Revenue and Forecasts to 2027 (US$ Million)

Figure 20.        Glytactin with GMP Market Revenue and Forecasts to 2027 (US$ Million)

Figure 21.        Amino Acid-Modified Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

Figure 22.        Low-Calcium/Vitamin D-Free Infant Formula With Iron Market Revenue and Forecasts to 2027 (US$ Million)

Figure 23.        Low Protein Food Market Revenue and Forecasts to 2027 (US$ Million)

Figure 24.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 25.        Medical Foods for Inborn Errors of Metabolism Market, by Age Group, 2019 & 2027 (%)

Figure 26.        Infants Market Revenue and Forecasts to 2027 (US$ Million)

Figure 27.        Weaning Market Revenue and Forecasts to 2027 (US$ Million)

Figure 28.        Adolescent Market Revenue and Forecasts to 2027 (US$ Million)

Figure 29.        Adults Market Revenue and Forecasts to 2027 (US$ Million)

Figure 30.        Medical Foods for Inborn Errors of Metabolism Market, by Disease, 2019 & 2027 (% Share)

Figure 31.        Phenylketonuria (PKU) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 32.        Maple Syrup Urine Disease(MSUD) Market Revenue and Forecasts to 2027 (US$ Million)

Figure 33.        Homocystinuria Market Revenue and Forecasts to 2027 (US$ Million)

Figure 34.        Urea Cycle Disorders Market Revenue and Forecasts to 2027 (US$ Million)

Figure 35.        Methylmalonic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

Figure 36.        Organic Acidurias Market Revenue and Forecasts to 2027 (US$ Million)

Figure 37.        Propionic Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

Figure 38.        Isovaleric Acidemia Market Revenue and Forecasts to 2027 (US$ Million)

Figure 39.        Disorders of Leucine Metabolism Market Revenue and Forecasts to 2027 (US$ Million)

Figure 40.        Glutaric Acidemia Type-I Market Revenue and Forecasts to 2027 (US$ Million)

Figure 41.        Renal Disease Market Revenue and Forecasts to 2027 (US$ Million)

Figure 42.        Tyrosinemia Type I and II Market Revenue and Forecasts to 2027 (US$ Million)

Figure 43.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 44.        Medical Foods for Inborn Errors of Metabolism Market, by Form, 2019 & 2027 (% Share)

Figure 45.        Powder Market Revenue and Forecasts to 2027 (US$ Million)

Figure 46.        Liquids Market Revenue and Forecasts to 2027 (US$ Million)

Figure 47.        Gels Market Revenue and Forecasts to 2027 (US$ Million)

Figure 48.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 49.        Medical Foods for Inborn Errors of Metabolism Market, by Packaging, 2019 & 2027 (% Share)

Figure 50.        Can Market Revenue and Forecasts to 2027 (US$ Million)

Figure 51.        Jar Market Revenue and Forecasts to 2027 (US$ Million)

Figure 52.        Packet Market Revenue and Forecasts to 2027 (US$ Million)

Figure 53.        Bottle Market Revenue and Forecasts to 2027 (US$ Million)

Figure 54.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 55.        Medical Foods for Inborn Errors of Metabolism Market, by Distribution Channel, 2019 & 2027 (% Share)

Figure 56.        Retail Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

Figure 57.        Hospital Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

Figure 58.        Online Pharmacies Market Revenue and Forecasts to 2027 (US$ Million)

Figure 59.        Drugstores Market Revenue and Forecasts to 2027 (US$ Million)

Figure 60.        Others Market Revenue and Forecasts to 2027 (US$ Million)

Figure 61.        North America: Medical Foods for Inborn Errors of Metabolism Market, by Key Country – Revenue (2019)  (USD Million)

Figure 62.        North America: Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecast to 2027  (USD Million)

Figure 63.        North America: Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

Figure 64.        US: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 65.        Canada: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 66.        Mexico:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 67.        Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

Figure 68.        Europe Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

Figure 69.        Europe: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

Figure 70.        Germany: Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 71.        UK: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 72.        France: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 73.        Spain: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 74.        Italy: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 75.        Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market, by Key Country – Revenue (2019)  (USD Million)

Figure 76.        Asia Pacific: Medical Foods for Inborn Errors of Metabolism Market Revenue and Forecast to 2027  (USD Million)

Figure 77.        Asia Pacific:Medical Foods for Inborn Errors of Metabolism Market, by Country, 2019 & 2027 (%)

Figure 78.        China:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 79.        Japan:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 80.        India:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 81.        South Korea:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

Figure 82.        Australia:Medical Foods for Inborn Errors of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 83.        Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country – Revenue (2019) (USD Million)

Figure 84.        Middle East and Africa Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

Figure 85.        Middle East and Africa: Medical Foods For Inborn Errors Of Metabolism Market, by Country, 2019 & 2027 (%)

Figure 86.        Saudi Arabia: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

Figure 87.        UAE: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027 (USD Million)

Figure 88.        South Africa: Medical Foods For Inborn Errors Of Metabolism Market– Revenue and Forecast to 2027  (USD Million)

Figure 89.        South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Key Country –  Revenue (2019) (USD Million)

Figure 90.        South and Central America Medical Foods For Inborn Errors Of Metabolism Market Revenue and Forecast to 2027 (USD Million)

Figure 91.        South and Central America: Medical Foods For Inborn Errors Of Metabolism Market, by Country,  2019 & 2027 (%)

Figure 92.        Brazil: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027 (USD Million)

Figure 93.        Argentina: Medical Foods For Inborn Errors Of Metabolism Market – Revenue and Forecast to 2027  (USD Million)

Figure 94.        Impact of COVID-19 Pandemic in North American Country Markets

Figure 95.        Impact of COVID-19 Pandemic in European Country Markets

Figure 96.        Impact of COVID-19 Pandemic in Asia-Pacific Country Markets

Figure 97.        Impact Of COVID-19 Pandemic in Rest of the World Countries Market

Figure 98.        Growth Strategies Done by the Companies in the Market, (%)

The List of Companies

  1. Nestlé Health Science
  2. Nutricia
  3. Solace Nutrition
  4. Abbott
  5. Mead Johnson and Company, LLC.
  6. BioMarin Pharmaceutical
  7. Ajinomoto Cambrooke, Inc.
  8. Poa Pharma
  9. PKU-MDmil
  10. Primus Pharmaceuticals, Inc.
  • Save and reduce time carrying out entry-level research by identifying the growth, size, leading players and segments in the medical foods for inborn errors of metabolism market.

 

  • Highlights key business priorities in order to assist companies to realign their business strategies.

 

  • The key findings and recommendations highlight crucial progressive industry trends in the global medical foods for inborn errors of metabolism market, thereby allowing players across the value chain to develop effective long-term strategies.

 

  • Develop/modify business expansion plans by using substantial growth offering developed and emerging markets.

 

  • Scrutinize in-depth global market trends and outlook coupled with the factors driving the market, as well as those hindering it.

 

  • Enhance the decision-making process by understanding the strategies that underpin security interest with respect to client products, segmentation, pricing and distribution.

 

TIPRE00011389
Your data will never be shared with third parties, however, we may send you information from time to time about our products that may be of interest to you. By submitting your details, you agree to be contacted by us. You may contact us at any time to opt-out.

Frequently Asked Questions

Medical food refers to the specialized kind of food formulated to be consumed under physician supervision and intended for specific dietary management of a particular disease or condition. These medical conditions usually have distinctive nutritional requirements based on scientific and recognized principles that are established by medical evaluation. The medical food differs from drugs; however they are intended for consumption under the medical supervision as a primary intervention. When infants are identified with inborn errors of metabolism, they are usually prescribed a special diet suitable to their particular condition that must be followed for the lifetime.

Factors such as increasing incidence of inborn errors of metabolism and increasing preference towards dietary food supplements are expected to boost the growth of the global medical foods for inborn errors of metabolism market. However, the market is likely to get impacted by the limitations associated to medical foods for inborn errors of metabolism during the forecast period.

North America is the largest market for the medical foods for inborn errors of metabolism market. The factors that are responsible for the dominance of the region include rising government support well-developed healthcare facilities, presence of top market players, increasing number of patients with inborn errors of metabolism and rising awareness regarding benefits of consuming nutritional supplements under medical supervision. Similarly, in Canada, increasing government initiatives to raise awareness regarding rare genetic disorders and well-established healthcare infrastructure are leading to market growth. Asia-Pacific is anticipated to register as the fastest-growing region in the global medical foods for inborn errors of metabolism market. The growth of the market is expected to be fastest in countries such as China, India, and Japan. The factors that are expected to drive the market growth include large number of patients suffering with genetic diseases and increasing launch of innovative products by local players in the Asian countries. Increasing collaborations and partnerships are also responsible for the growth of the market in the Asian region.

Pricing